Avene Cleanance Face & Eye Micellar Water for Combination, Oily, Blemish-prone Skin 400ml

Avène Cleanance Micellar Cleansing Water for oily, blemish-prone skin, providing a matte finish (400 ml). Formulated with 99% ingredients of natural origin, this micellar water removes makeup with just the first cotton pad¹ and eliminates even fine pollution particles, leaving the skin clean, fresh, and matte. Enriched with Avène Thermal Spring Water and glycerin, its formula ensures gentle cleansing and helps restore the skin's natural balance. ¹Sensory profile assessed by 15 trained panelists.

Benefits:

• Makeup removal: face and eyes, with just the first cotton pad*.
• Cleansing: Removes impurities and pollution particles.
• Matte finish: Reduces excess sebum thanks to glutamic acid.
• A fresh, pleasant texture that is non-sticky, leaving the skin feeling soft.
• Packaging made primarily from recyclable materials.

* Sensory profile assessed by 15 trained panelists.

Routine:
Apply to the face and eyes using a cotton pad, morning and/or evening. No rinsing required. For added softness, finish by misting with Avène Thermal Spring Water.

Use:

Daily use: Apply to your face and eyes using a cotton pad, morning and/or evening. No rinsing required. For extra softness, finish by misting with Avène Thermal Spring Water. Expert tip: Combination or oily skin can also be sensitive, so remember to remove your makeup gently!
How to:
• Place the cotton pad between your little finger and index finger.
• Cleanse or remove makeup by keeping your fingers flat and sweeping the pad from the center of the face outwards. This technique allows for gentler makeup removal than holding the pad with just your fingertips. Features and Benefits

Biodegradable Formula:

• skin feels soft to the touch, matte, clean, fresh, and purified¹
• significantly reduces excess sebum and the appearance of pores after 14 days²

¹49 women with oily, acne-prone skin. 2 applications daily on the face for 29 days. Self-assessment.
²Measurement using Sebutape (p<0.001 vs. T0), tolerance and efficacy study, 49 subjects, 2 applications daily for 29 days.